logo

For the Inventor, By the Inventor

Fukuoka, Japan

Kenji Sunagawa

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 262(Granted Patents)


Company Filing History:

goldMedal6 out of 49 
 
National Cerebral and Cardiovascular Center
 patents
silverMedal6 out of 442 
 
Fujikin Inc.
 patents
bronzeMedal3 out of 433 
 
Kyushu University
 patents
4. 2 out of 13 
 
Japan Health Sciences Foundation
 patents
5. 2 out of 265 
 
Abiomed, Inc.
 patents
6. 1 out of 1 
 
Fujikin Corporated
 patent
where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12329956 - Systems and methods for controlling a heart pump to minimize myocardial oxygen consumption (2025-06-17),
2. 11969597 - Blood pressure controlling apparatus, non-transitory computer readable recording medium storing control program of blood pressure controlling apparatus, and method for controlling blood pressure (2024-04-30),
3. 10960118 - Systems and methods for controlling a heart pump to minimize myocardial oxygen consumption (2021-03-30),
4. 9242096 - Stimulation device and method for treating cardiovascular disease (2016-01-26),
5. 9227079 - Stimulation device and method for treating cardiovascular disease (2016-01-05),
6. 8340749 - System for automatically minimizing cardiac oxygen consumption and cardiac disease treating system using the same (2012-12-25),
7. 8282563 - Cardiac disease treatment system (2012-10-09),
8. 8027729 - Micro integrated cardiac pacemaker and distributed cardiac pacing system (2011-09-27),
9. 8010199 - Blood pressure regulating system by substituting native biological regulatory function (2011-08-30),
10. 8010195 - Cardiac pacing system by substituting native biological regulatory function (2011-08-30),
11. 8000791 - Cardiac pacing system and distributed cardiac pacing system (2011-08-16),
12. 7962216 - Cardiac pacing system, blood pressure regulating system, and cardiac disease treatment system by substituting native biological regulatory function (2011-06-14),
13. 7835791 - Medical treatment system using biological regulation function alternate, cardiac pacing system based on the medical treatment system, blood pressure regulating system, and cardiac disease treating system (2010-11-16),

Title: Kenji Sunagawa: Innovator in Cardiovascular Technology

Introduction

Kenji Sunagawa is a prominent inventor based in Fukuoka, Japan, known for his significant contributions to cardiovascular technology. With a total of 13 patents to his name, he has developed innovative systems and methods aimed at improving heart health and treatment for patients suffering from acute myocardial infarction.

Latest Patents

One of Sunagawa's latest patents focuses on systems and methods for controlling a heart pump to minimize myocardial oxygen consumption. This invention is designed to treat acute myocardial infarction (AMI) patients by maximizing mechanical unloading of the left ventricle while minimizing myocardial oxygen consumption and infarct size. The system includes a sensor that measures left ventricular systolic pressure (LVSP) and a controller that operates the heart pump based on this measurement.

Another notable patent is a blood pressure controlling apparatus that acquires biological information indicating a subject's blood pressure. This apparatus produces a frequency-modulated pulse train based on the acquired information and supplies an electrical current to stimulate baroreceptor afferent nerves, thereby aiding in blood pressure regulation.

Career Highlights

Throughout his career, Kenji Sunagawa has worked with esteemed organizations such as the National Cerebral and Cardiovascular Center and Fujikin Inc. His work in these institutions has allowed him to collaborate on groundbreaking research and development in the field of cardiovascular health.

Collaborations

Sunagawa has collaborated with notable professionals in his field, including Masaru Sugimachi and Takayuki Sato. These partnerships have contributed to the advancement of innovative solutions in cardiovascular technology.

Conclusion

Kenji Sunagawa's contributions to cardiovascular technology through his patents and collaborations highlight his commitment to improving heart health. His innovative approaches continue to influence the medical field and provide hope for patients with heart conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…